Oxygen Therapy Equipment Market
Oxygen Therapy Equipment Market Analysis by Product, By Portability, By Application, By End-User and By Region - Global Market Insights 2025 to 2025
Analysis of the Oxygen Therapy Equipment Market Covering 30 + Countries, Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Oxygen Therapy Equipment Market Outlook (2025 to 2035)
The worldwide oxygen therapy equipment market is expected to see tremendous growth from USD 4.2 billion in 2025 to USD 10.2 billion in 2035, growing at a CAGR of 8.9% during the forecast period. The growth is fueled by the rising incidence of chronic respiratory disorders, especially COPD and the growing geriatric population, and increased awareness of home-based oxygen therapy solutions.
Growing developments in technology across oxygen delivery solutions and the increasing proliferation of portable oxygen concentrators are also driving factors for sales expansion. With the need for effective respiratory care on the rise across the world, oxygen therapy is becoming more integrated into hospital and homecare settings.
Physicians are actively turning towards non-invasive respiratory care, particularly for post-operative treatment, COVID-19 recovery and management of chronic respiratory diseases. This is promoting investment in portable, easy-to-use devices that provide constant oxygenation with real-time monitoring capabilities.
The other significant driving force is a global rise in air pollution that has led to a rising number of respiratory illnesses in metropolitan areas. Along with this has been increased accessibility to healthcare within growing economies, and this has translated into the wider use of oxygen therapy as a vital intervention. Governments, as well as healthcare authorities, are further offering positive reimbursement schemes to finance the purchase of oxygen therapy machines.
In the meantime, innovation continues to be at the heart of competitive differentiation. Leading players are making efforts to enhance the ergonomics and portability of oxygen concentrators and cylinders, include digital control panels, and provide Bluetooth-compatible health monitoring systems. These features will be likely to drive consumer choice and encourage consistent use, especially among home-bound and elderly patients.
During the forecast period, the industry is set for consolidation as businesses increasingly seek collaboration with healthcare providers and home care services to broaden their reach. With respiratory health taking center stage on global health agendas, particularly in the wake of the COVID-19 pandemic, the oxygen therapy equipment market is set to continue its upward trend up to 2035
Key Metrics
Metric | Value |
---|---|
Estimated Global Size in 2025 | USD 4.2 Billion |
Projected Global Size in 2035 | USD 10.2 Billion |
CAGR (2025 to 2035) | 8.9% |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Fact.MR Survey Results: Industry Dynamics Based on Stakeholder Perspectives
Stakeholder commentary from the oxygen therapy equipment marketplace indicates a dramatic worldwide shift to patient-focused, technology-driven solutions. Fact.MR's study discovered that 81% of healthcare professionals cite dependable home-based systems to help chronic care, with portable appliances preferred in North America and efficient, low-power systems prioritized in Europe.
Affordability and reliability across rural areas prioritized stakeholder concerns in the Asia-Pacific. Throughout geography, stakeholders are positioning their efforts according to changing demographics, ecological objectives, and regional health programs.
The utilization of cutting-edge technologies is redesigning competitive positions. North American vendors are placing app-enabled concentrators, with a noise-reduction focus in Europe and solar-backup emphasis in Asia-Pacific. Yet, challenges of a system-wide nature endure.
Disparate last-mile supply chain logistics, bureaucratic delays within Europe, and inadequately trained maintenance personnel in Asia continue to impede adoption on a mass scale. Despite these limitations, 78% of stakeholders intend to invest in oxygen flow systems with AI integration, region-specific priorities such as recyclable products in Europe and scalable models for rural deployment in Asia-Pacific.
Fact.MR analysis highlights that expansion will depend on digitalization, regulatory flexibility, and strategic partnerships. Dangers like supply chain turbulence and technology slowdown are still present, while the boardroom agenda has to be focused on crisis readiness, compliance drive, and customization of oxygen supply. Organizations focusing on intelligent, energy-saving, and geographically adaptable solutions have the potential to shape the future of respiratory therapy.
Shifts in the Market from 2020 to 2024 and Future Trends 2025 to 2035
During the years between 2020 and 2024, the oxygen therapy equipment market showed considerable growth driven mainly by the international health emergency that raised sensitivity toward respiratory disease. There was increased demand for portable oxygen concentrators and home-use oxygen therapy systems as hospitals and patients looked for convenient and easily accessible therapies.
Manufacturers aimed at enhancing device portability, noise reduction, and user-friendliness. Further, the expanded use of non-invasive oxygen therapy and wearable devices facilitated outpatient therapy and patient autonomy.
Between 2025 and 2035, the oxygen therapy equipment market will change with smart technology and evidence-based models of care. Technology will be networked, smarter, and smaller, and remote monitoring and control will be done through an app, making it easier to manage chronic respiratory disease. Diagnostics and predictive analytics based on artificial intelligence will optimize oxygen usage and delivery.
Green material application and sustainable production will also influence design. Personalized oxygen treatment, with machines conforming to specific respiratory patterns, will enhance patient outcomes and alleviate pressure on healthcare systems.
Comparative Market Shift Analysis 2020 to 2024 vs. 2025 to 2035
2020 to 2024 | 2025 to 2035 |
---|---|
Epidemic-level high demand for treating respiratory disease | Increased awareness leads to heightened demand |
Growth over the long term fueled by chronic respiratory management and aging demographics | More focus on light, transportable, and domiciliary oxygen devices |
Intelligence, connectivity, and adaptability in oxygen devices | Advancements in quiet levels, battery usage, and patient friendliness |
Incorporation of artificial intelligence, distant monitoring, and individualized features | Expanded presence in the home and outpatient facilities to lower the care burden |
Scaling telemedicine-facilitated oxygen therapy and home care models | Prioritizing emergency demand fulfillment through scalable manufacturing |
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis
Countries | CAGR (2025 to 2035) |
---|---|
USA | 7.6% |
UK | 6.3% |
France | 6.0% |
Germany | 6.5% |
Italy | 5.9% |
South Korea | 6.7% |
Japan | 6.4% |
China | 8.1% |
Australia-NZ | 6.2% |
The USA
The USA oxygen therapy equipment market is anticipated to expand at 7.6% CAGR throughout the period under study. The oxygen therapy equipment market in the USA is likely to experience long-term growth owing to a widespread incidence of chronic respiratory diseases like COPD, asthma, and sleep apnea.
An aging population, combined with the sophisticated healthcare infrastructure in the country, enables the mass use of home-based oxygen therapy devices. Besides, good reimbursement structures and more healthcare expenditures facilitate accessibility among providers and patients. Technologies like portable oxygen concentrators and wearable oxygen devices are greatly driving sales penetration.
Also, greater awareness of the value of early treatment of respiratory diseases is fueling the growing demand. Major industry players are undertaking research and development efforts to make more efficient and smaller devices available.
Increasing interest in telemedicine and remote monitoring of patients is also making the integration of oxygen therapy systems at a broader scale into homecare models easier, helping the transition from hospital-centered to decentralized healthcare environments. Overall, the United States oxygen therapy equipment continues to be upbeat based on innovation, policy, and a mature healthcare consumer base that is complex.
UK
The UK oxygen therapy equipment market will register a 6.3% CAGR throughout the study period. Both healthcare modernization and greater emphasis on home healthcare service fuel the expansion of the oxygen therapy equipment market in the UK. Chronic respiratory diseases are among the foremost reasons for hospitalization, and therefore, national healthcare efforts are strengthening provisions for home oxygen therapy solutions.
The UK's National Health Service (NHS) has promoted self-management of chronic respiratory conditions proactively, helping expand the oxygen therapy equipment market. There is a clear trend toward light, portable oxygen devices enhancing patient mobility and quality of life. Integration of digital technology with oxygen delivery systems has become popular, allowing for more accurate dosage and monitoring outside the hospital environment.
Besides that, environmental and public health regulations to curtail smoking and air pollution have secondary benefits in boosting awareness and handling respiratory diseases. Players in the UK's oxygen therapy equipment market enjoy a secure regulatory setting that supports development while guaranteeing safety levels. Even though there are constraints within the healthcare budget, government commitment to managing chronic diseases means oxygen therapy continues as a priority level in both in-hospital and domiciliary management.
France
France's oxygen therapy equipment market will grow at a rate of 6.0% CAGR in the forecasting period. The French oxygen therapy equipment market is observing a uniform expansion in oxygen therapy equipment growth based on a higher incidence rate of chronic respiratory disease and growing older populations. National policies concerning health care are emphasizing stronger decentralization efforts in terms of healthcare, consequently accelerating demand for oxygen therapy solutions based on at-home usage.
Regional variations in the delivery of healthcare have also spurred the rising uptake of transportable oxygen equipment that allows continued care beyond institutional settings. Product design innovations such as improved battery life and reduced weight have resulted in more user-friendly devices suitable for patients leading active lives. The French system of care promotes partially reimbursed oxygen therapy in eligible conditions, which ensures continuity of use within urban and rural settings.
Effective partnerships among hospitals, device companies, and telehealth organizations are yielding improved patient outcomes and greater accessibility. Furthermore, environmental issues and rising levels of air pollution have created a greater societal interest in respiratory health, indirectly fueling the demand in the oxygen therapy equipment market. The industry trend is positive, with ongoing efforts towards technological integration and patient-centric care.
Germany
Germany's oxygen therapy equipment market is likely to expand at 6.5% CAGR over the study period. Germany boasts a strong healthcare system with high chronic disease management, which makes it a prominent stakeholder in the oxygen therapy equipment market. A rising population of older adults and a well-developed network of healthcare professionals provide strength to the oxygen therapy equipment market. Germany also boasts one of the highest rates of treatment and diagnosis of COPD in Europe, backing persistent demand for oxygen delivery systems.
Industry expansion is underpinned by robust insurance coverage of long-term therapy and forward-looking hospital discharge planning that encompasses home oxygen services. Technological advancements such as smart oxygen concentrators featuring real-time monitoring are becoming increasingly popular.
German patients also prefer energy-saving and noise-reducing oxygen systems, leading manufacturers to emphasize user comfort and device longevity. Compliance with European regulations also guarantees the introduction of high-quality equipment, enhancing patient confidence. Ongoing investment in research and regional distribution networks will most likely drive future growth and open up new opportunities for domestic and international suppliers.
Italy
The Italian oxygen therapy equipment market will grow at a 5.9% CAGR throughout the study period. Italy has moderate growth opportunities for the oxygen therapy equipment market, which is stimulated by the increasing burden of chronic respiratory disease and a progressively aging population. The national health system facilitates access to basic oxygen therapy, though regional variations in the delivery of services are challenging for uniform distribution of the devices.
Demand for portable oxygen concentrators is growing, particularly among older patients needing ambulatory oxygen therapy. Still, Italy's decentralized healthcare system sometimes hinders the adoption of newer technologies in all areas. Public hospitals and caregivers are slowly adopting digital oxygen delivery systems with embedded sensors to enable remote monitoring and prompt intervention.
Key players are concentrating on forging alliances with local distributors to enhance equipment availability and maintenance support. In spite of administrative barriers, the nation's strategic emphasis on aging and respiratory care guarantees steady, if paced, growth in the application of complex oxygen therapy equipment.
South Korea
The South Korean oxygen therapy equipment market is likely to expand at 6.7% CAGR throughout the research period. South Korea has high potential in the oxygen therapy equipment market, influenced predominantly by technology readiness and an aggressively aging population. Urbanization, as well as high air pollution rates, lead to an increased rate of respiratory diseases such as asthma and COPD. The government's efforts to digitalize healthcare and increase homecare services are driving the uptake of oxygen therapy solutions.
A significant consumer trend toward mobile and wearable oxygen therapy devices, particularly among city residents needing convenience and freedom of movement, exists. The adoption of oxygen therapy equipment with smartphone applications and remote monitoring platforms is consonant with South Korea's robust digital network infrastructure, supporting real-time patient interaction.
Nationwide health insurance further offers extensive support for the management of chronic diseases, making widespread access to necessary respiratory aids highly affordable. The increasing need for individualized healthcare and real-time sharing of data positions South Korea in the lead among digital oxygen therapy solutions, with the industry set for rapid growth.
Japan
The Japanese oxygen therapy equipment market is likely to expand at a 6.4% CAGR over the analysis period. The oxygen therapy equipment market in Japan is marked by consistent growth, driven by a long life expectancy and a significant morbidity burden of chronic respiratory diseases among the geriatric population. The universal healthcare system of the country enables patients to get early diagnosis and long-term treatment of respiratory diseases, favoring consistent demand for oxygen concentrators, cylinders, and other devices.
The oxygen therapy equipment market is also seeing a boost in the usage of small, quiet, and efficient oxygen therapy systems designed specifically for home care. Japan's focus on innovation in technology ensures a steady flow of next-generation devices with in-built smart technologies.
A focus on the quality of life of the elderly has spurred the growth of ergonomic and easy-to-use products that allow for independence. In addition, medical professionals are adopting AI-supported solutions for respiratory care, strengthening the position of oxygen therapy in long-term care strategies. Japan's early adoption of chronic disease treatment and health technology development places the country at the forefront.
China
The China oxygen therapy equipment market is anticipated to increase at 8.1% CAGR throughout the research period. China is the regional leader because of the convergence of high incidence of respiratory diseases, increased urbanization, and growing levels of air pollution.
The government's drive to enhance the healthcare infrastructure across urban and rural areas has hugely improved the accessibility of oxygen therapy equipment. Increased disposable income and expanding knowledge about the management of chronic diseases have further enhanced the adoption of this equipment.
Local manufacturers in China provide affordable, scalable oxygen therapy options. Technology upgrades and collaborations with digital health companies have brought forth smart oxygen concentrators that offer real-time monitoring.
The nation's growing proportion of older adults, coupled with the nation's heightened focus on home-based and community-level care, is set to fuel enduring demand. Regulatory reforms for the promotion of medical device innovation and quicker product approvals are contributing to a positive environment for both domestic and global industry participants.
Australia-New Zealand
The Australia-New Zealand oxygen therapy equipment market will be growing at 6.2% CAGR over the study period. Both Australia and New Zealand together provide a secure and mature oxygen therapy equipment market fueled by sophisticated healthcare infrastructures and intensive patient-focused care. The incidence of respiratory diseases like COPD and sleep apnea is increasing, providing a strong base for demand.
Both nations focus on home and community-based care, which bodes well for the portability and convenience of newer oxygen delivery systems. Government-sponsored healthcare programs cover long-term oxygen therapy, enhancing patients' access to equipment. Industry participants are investing in telehealth-ready solutions that are integrated within comprehensive respiratory care platforms.
Environmental issues, such as seasonal wildfires and air pollution, have also highlighted concerns about respiratory health, which contribute indirectly to equipment uptake. The regulatory framework supports innovation with a continuous inflow of technologically enhanced and safe products. Lifestyle-based delivery of healthcare will continue to propel the demand for adaptable and customized oxygen therapy solutions in the region.
Segment-wise Analysis
By Portability
Stationary oxygen devices account for a share of 61.4%, and portable oxygen devices will occupy 38.6% of the industry.
Stationary oxygen equipment is favored for its high oxygen output and feasibility of long-term use at lower costs. Patients needing continuous supplies of oxygen due to chronic respiratory diseases, such as COPD, pulmonary fibrosis, and emphysema, are generally accommodated with the use of stationary devices like home oxygen concentrators and liquid oxygen systems.
Philips Healthcare and Invacare are some of the major industry players that manufacture the Philips Respironics EverFlo and Invacare Platinum XL oxygen concentrators, which are the most used. Rightfully termed "workhorses," these devices are known for their reliability, low maintenance, and high flow rates suitable for long-term therapy, together with Linde Healthcare, which manufactures liquid oxygen systems and oxygen concentrators, thus enhancing the growth of the stationary segment by pursuing energy-efficient and user-friendly solutions.
Portable units in oxygen therapy devices are predicted to occupy a share of about 38.6% as they offer the highest degree of mobility and ease of handling. Oxygen therapy patients travel wherever they need to go, often with their portable oxygen concentrators (POCs) and portable cylinders. Such portable devices are especially useful for patients with severe respiratory problems who require supplemental oxygen for travel, exercise, or simply in daily life.
Inogen, a Singapore-based company with innovations such as the Inogen One G5 and O2 Concepts' Oxlife Independence Model, specializes in the development of lightweight, compact, and durable devices with prolonged battery life. Battery technology advances and miniaturization of components have increased portability and convenience attractiveness, thus making these portable devices capable of catering to busy patients' needs.
By Product
Oxygen Source Equipment is projected to have a 51.2% share in the oxygen therapy equipment market by the year 2025, while oxygen delivery devices will capture 48.8%.
Oxygen Source Equipment comprises the largest segment in the industry, contributing to the industry with more than 51% of its shares. In this segment are oxygen concentrators and liquid oxygen systems, which are important to ensure a continuous and dependable supply of oxygen. The oxygen concentrator works on the principle of filtration and concentration, separating oxygen from air within a home or clinical setting.
Among the leaders in this segment are Philips Health Care and Invacare, which use their Philips EverFlo and Invacare Platinum models. It is being widely used due to its efficiency and long-term cost-effectiveness, with a continuous capacity to deliver oxygen to patients with chronic respiratory diseases such as COPD or pulmonary fibrosis.
Linde Healthcare also offers liquid oxygen systems for patients who use more significant oxygen flow. The burgeoning demand for home healthcare services and long-term care for respiratory management will be a substantial contributor to the growth of this segment. At the same time, enhanced product reliability and reduced energy consumption levels will drive growth.
Oxygen Delivery Devices, which hold 48.8% of the share, are the link between the source equipment and the patient and thus ensure that the oxygen delivered is effective; it is subcategorized into devices for nasal cannulas, face masks, oxygen tubing, and non-invasive ventilation. The demand for delivery devices is derived from the rising number of patients on home oxygen therapy and the convenience, comfort, and efficacy of the method of delivery.
CareFusion (a part of BD) and Salter Labs manufacture various delivery devices, including the Salter 1600 nasal cannula, emphasizing patient comfort and optimizing the flow of oxygen. The rise of chronic respiratory disease prevalence, along with demand for portable solutions, has propelled innovation in this arena, including extended-use nasal prongs and high-flow oxygen masks aimed toward patients with more severe conditions.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Outlook
The oxygen therapy equipment market in 2025 is characterized by a mature yet highly responsive competitive environment. Core competition centers around the design and distribution of high-efficiency oxygen delivery systems, with differentiation driven by portability, automation, and long-term home care adaptability. While hospitals remain a key segment, the shift toward home-based and ambulatory oxygen therapy continues to reshape product design and vendor strategies.
Philips Healthcare and Inogen lead in innovation and sales penetration, with a strong emphasis on portable oxygen concentrators and user-friendly digital interfaces. Teleflex and Drägerwerk are notable for their presence in acute care, focusing on ventilator-integrated oxygen systems and smart flow regulation. Meanwhile, companies like Chart Industries and Linde Healthcare strengthen the industry with cryogenic and liquid oxygen solutions essential for both clinical and industrial-medical hybrid use.
Product innovation is increasingly focused on miniaturization, noise reduction, and energy efficiency. The integration of real-time oxygen saturation monitoring and app-based patient compliance tools has added layers of patient engagement and clinical data utility, enhancing both outcomes and product loyalty.
Strategic partnerships with remote monitoring platforms and acquisitions in the respiratory care segment are reshaping the positioning of industries. Players are leveraging data-driven respiratory analytics and wearable tech alliances to deliver holistic patient management beyond just oxygen supply.
Market Share Analysis by Company
Company Name | Estimated Market Share (%) |
---|---|
Philips Healthcare | 18-21% |
Inogen, Inc. | 15-18% |
Teleflex Inc. | 13-15% |
Drägerwerk AG & Co. KGaA | 10-12% |
Chart Industries, Inc. | 8-10% |
Other Companies Combined | 24-28% |
Key Company Insights
Philips Healthcare (18-21%)
Philips dominates with a comprehensive line of concentrators and digital health integration, focusing on both clinical reliability and consumer usability for chronic respiratory patients.
Inogen, Inc. (15-18%)
Inogen’s stronghold lies in ultra-portable devices and direct-to-consumer strategies, enabling independence for patients while enhancing digital tracking of therapy compliance.
Teleflex Inc. (13-15%)
Teleflex supports hospitals with integrated respiratory portfolios, including advanced masks, humidifiers, and high-flow nasal systems for acute oxygen management.
Drägerwerk AG & Co. KGaA (10-12%)
Drägerwerk’s systems cater to critical care units, offering intelligent ventilation features and precision-controlled oxygen delivery in complex clinical settings.
Chart Industries, Inc. (8-10%)
Chart offers scalable oxygen delivery infrastructure, bridging hospital and home care with durable cryogenic storage and innovative low-pressure delivery systems.
Key Market Players
- Philips Healthcare
- Inogen, Inc.
- Teleflex Inc.
- Drägerwerk AG & Co. KGaA
- Chart Industries, Inc.
- Smiths Medical
- GE Healthcare
- Invacare Corporation
- Linde Healthcare
- Fisher & Paykel Healthcare Ltd.
- Taiyo Nippon Sanso Corporation
Segmentation
-
By Portability:
- Stationary
- Portable
-
By Product:
- Oxygen Source Equipment
- Oxygen Delivery Devices
-
By Application:
- COPD
- Asthma
- Cystic Fibrosis
- Pneumonia
- Others
-
By End User:
- Hospitals
- Home Care
- Ambulatory Surgical Centers
- Physician Offices
- Others
-
By Region:
- North America
- Europe
- East Asia
- South Asia
- Latin America
- Middle East & Africa (MEA)
- Oceania
Table of Content
- Executive Summary
- Market Overview
- Market Background
- Global Market Pricing Analysis
- Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035)
- Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Portability
- 6.1. Stationary
- 6.2. Portable
- Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Product
- 7.1. Oxygen Source Equipment
- 7.2. Oxygen Delivery Devices
- Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Application
- 8.1. COPD
- 8.2. Asthma
- 8.3. Cystic Fibrosis
- 8.4. Pneumonia
- 8.5. Others
- Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by End User
- 9.1. Hospitals
- 9.2. Home Care
- 9.3. Ambulatory Surgical Centers
- 9.4. Physician Offices
- 9.5. Others
- Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- North America Market Analysis and Forecast
- Europe Market Analysis and Forecast
- East Asia Market Analysis and Forecast
- South Asia Market Analysis and Forecast
- Latin America Market Analysis and Forecast
- Middle East & Africa Market Analysis and Forecast
- Oceania Market Analysis and Forecast
- Global Market Analysis Key Countries
- Competition Landscape
- Competition Analysis
- 20.1. Philips Healthcare
- 20.2. Smiths Medical
- 20.3. Teleflex Inc.
- 20.4. GE Healthcare
- 20.5. Invacare Corporation
- 20.6. Linde Healthcare
- 20.7. Chart Industries, Inc.
- 20.8. Dragerwerk AG & Co. KGaA
- 20.9. Fisher & Paykel Healthcare Ltd.
- 20.10. Inogen, Inc.
- 20.11. Taiyo Nippon Sanso Corporation
- Appendix
- Definitions of Analytical Frameworks
- Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Portability, 2020 to 2035
Table 02: Global Market Value (USD Million), by Portability, 2020 to 2035
Table 03: Global Market Volume (Units), by Product, 2020 to 2035
Table 04: Global Market Value (USD Million), by Product, 2020 to 2035
Table 05: Global Market Volume (Units), by Application, 2020 to 2035
Table 06: Global Market Value (USD Million), by Application, 2020 to 2035
Table 07: Global Market Volume (Units), by End User, 2020 to 2035
Table 08: Global Market Value (USD Million), by End User, 2020 to 2035
Table 09: Global Market Volume (Units), by Region, 2020 to 2035
Table 10: Global Market Value (USD Million), by Region, 2020 to 2035
Table 11: North America Market Volume (Units), by Portability, 2020 to 2035
Table 12: North America Market Value (USD Million), by Portability, 2020 to 2035
Table 13: North America Market Volume (Units), by Product, 2020 to 2035
Table 14: North America Market Value (USD Million), by Product, 2020 to 2035
Table 15: North America Market Volume (Units), by Application, 2020 to 2035
Table 16: North America Market Value (USD Million), by Application, 2020 to 2035
Table 17: North America Market Volume (Units), by End User, 2020 to 2035
Table 18: North America Market Value (USD Million), by End User, 2020 to 2035
Table 19: North America Market Volume (Units), by Country, 2020 to 2035
Table 20: North America Market Value (USD Million), by Country, 2020 to 2035
Table 21: Europe Market Volume (Units), by Portability, 2020 to 2035
Table 22: Europe Market Value (USD Million), by Portability, 2020 to 2035
Table 23: Europe Market Volume (Units), by Product, 2020 to 2035
Table 24: Europe Market Value (USD Million), by Product, 2020 to 2035
Table 25: Europe Market Volume (Units), by Application, 2020 to 2035
Table 26: Europe Market Value (USD Million), by Application, 2020 to 2035
Table 27: Europe Market Volume (Units), by End User, 2020 to 2035
Table 28: Europe Market Value (USD Million), by End User, 2020 to 2035
Table 29: Europe Market Volume (Units), by Country, 2020 to 2035
Table 30: Europe Market Value (USD Million), by Country, 2020 to 2035
Table 31: East Asia Market Volume (Units), by Portability, 2020 to 2035
Table 32: East Asia Market Value (USD Million), by Portability, 2020 to 2035
Table 33: East Asia Market Volume (Units), by Product, 2020 to 2035
Table 34: East Asia Market Value (USD Million), by Product, 2020 to 2035
Table 35: East Asia Market Volume (Units), by Application, 2020 to 2035
Table 36: East Asia Market Value (USD Million), by Application, 2020 to 2035
Table 37: East Asia Market Volume (Units), by End User, 2020 to 2035
Table 38: East Asia Market Value (USD Million), by End User, 2020 to 2035
Table 39: East Asia Market Volume (Units), by Country, 2020 to 2035
Table 40: East Asia Market Value (USD Million), by Country, 2020 to 2035
Table 41: South Asia Market Volume (Units), by Portability, 2020 to 2035
Table 42: South Asia Market Value (USD Million), by Portability, 2020 to 2035
Table 43: South Asia Market Volume (Units), by Product, 2020 to 2035
Table 44: South Asia Market Value (USD Million), by Product, 2020 to 2035
Table 45: South Asia Market Volume (Units), by Application, 2020 to 2035
Table 46: South Asia Market Value (USD Million), by Application, 2020 to 2035
Table 47: South Asia Market Volume (Units), by End User, 2020 to 2035
Table 48: South Asia Market Value (USD Million), by End User, 2020 to 2035
Table 49: South Asia Market Volume (Units), by Country, 2020 to 2035
Table 50: South Asia Market Value (USD Million), by Country, 2020 to 2035
Table 51: Latin America Market Volume (Units), by Portability, 2020 to 2035
Table 52: Latin America Market Value (USD Million), by Portability, 2020 to 2035
Table 53: Latin America Market Volume (Units), by Product, 2020 to 2035
Table 54: Latin America Market Value (USD Million), by Product, 2020 to 2035
Table 55: Latin America Market Volume (Units), by Application, 2020 to 2035
Table 56: Latin America Market Value (USD Million), by Application, 2020 to 2035
Table 57: Latin America Market Volume (Units), by End User, 2020 to 2035
Table 58: Latin America Market Value (USD Million), by End User, 2020 to 2035
Table 59: Latin America Market Volume (Units), by Country, 2020 to 2035
Table 60: Latin America Market Value (USD Million), by Country, 2020 to 2035
Table 61: Middle East and Africa Market Volume (Units), by Portability, 2020 to 2035
Table 62: Middle East and Africa Market Value (USD Million), by Portability, 2020 to 2035
Table 63: Middle East and Africa Market Volume (Units), by Product, 2020 to 2035
Table 64: Middle East and Africa Market Value (USD Million), by Product, 2020 to 2035
Table 65: Middle East and Africa Market Volume (Units), by Application, 2020 to 2035
Table 66: Middle East and Africa Market Value (USD Million), by Application, 2020 to 2035
Table 67: Middle East and Africa Market Volume (Units), by End User, 2020 to 2035
Table 68: Middle East and Africa Market Value (USD Million), by End User, 2020 to 2035
Table 69: Middle East and Africa Market Volume (Units), by Country, 2020 to 2035
Table 70: Middle East and Africa Market Value (USD Million), by Country, 2020 to 2035
Table 71: Oceania Market Volume (Units), by Portability, 2020 to 2035
Table 72: Oceania Market Value (USD Million), by Portability, 2020 to 2035
Table 73: Oceania Market Volume (Units), by Product, 2020 to 2035
Table 74: Oceania Market Value (USD Million), by Product, 2020 to 2035
Table 75: Oceania Market Volume (Units), by Application, 2020 to 2035
Table 76: Oceania Market Value (USD Million), by Application, 2020 to 2035
Table 77: Oceania Market Volume (Units), by End User, 2020 to 2035
Table 78: Oceania Market Value (USD Million), by End User, 2020 to 2035
Table 79: Oceania Market Volume (Units), by Country, 2020 to 2035
Table 80: Oceania Market Value (USD Million), by Country, 2020 to 2035
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (USD Thousand) and Y-o-Y Growth, 2020 to 2035
Fig 02: Global Absolute USD Historical Market (2020 to 2024) and Absolute USD Opportunity (2025 to 2035), USD Million
Fig 03: Global Absolute Historical Volume Market (2020 to 2024) and Absolute Volume Opportunity (2025 to 2035), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2020 to 2035
Fig 05: Global Market Incremental USD Opportunity (USD Thousand), 2025 to 2035
Fig 06: Global Market Share, By Portability to 2025 to 2035
Fig 07: Global Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 08: Global Market Attractiveness Index, By Portability to 2025 to 2035
Fig 09: Global Market Share, By Product to 2025 to 2035
Fig 10: Global Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 11: Global Market Attractiveness Index, By Product to 2025 to 2035
Fig 12: Global Market Share, By Application to 2025 to 2035
Fig 13: Global Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 14: Global Market Attractiveness Index, By Application to 2025 to 2035
Fig 15: Global Market Share, By End User to 2025 to 2035
Fig 16: Global Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 17: Global Market Attractiveness Index, By End User to 2025 to 2035
Fig 18: Global Market Share, by Region to 2025 to 2035
Fig 19: Global Market Y-o-Y Growth Projections, by Region to 2025 to 2035
Fig 20: Global Market Attractiveness Index, by Region to 2025 to 2035
Fig 21: North America Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Portability to 2025 to 2035
Fig 24: North America Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 25: North America Market Attractiveness Index, By Portability to 2025 to 2035
Fig 26: North America Market Share, By Product to 2025 to 2035
Fig 27: North America Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 28: North America Market Attractiveness Index, By Product to 2025 to 2035
Fig 29: North America Market Share, By Application to 2025 to 2035
Fig 30: North America Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 31: North America Market Attractiveness Index, By Application to 2025 to 2035
Fig 32: North America Market Share, By End User to 2025 to 2035
Fig 33: North America Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 34: North America Market Attractiveness Index, By End User to 2025 to 2035
Fig 35: North America Market Share, By Country to 2025 to 2035
Fig 36: North America Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 37: North America Market Attractiveness Index, By Country to 2025 to 2035
Fig 38: Europe Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Portability to 2025 to 2035
Fig 41: Europe Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 42: Europe Market Attractiveness Index, By Portability to 2025 to 2035
Fig 43: Europe Market Share, By Product to 2025 to 2035
Fig 44: Europe Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 45: Europe Market Attractiveness Index, By Product to 2025 to 2035
Fig 46: Europe Market Share, By Application to 2025 to 2035
Fig 47: Europe Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 48: Europe Market Attractiveness Index, By Application to 2025 to 2035
Fig 49: Europe Market Share, By End User to 2025 to 2035
Fig 50: Europe Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 51: Europe Market Attractiveness Index, By End User to 2025 to 2035
Fig 52: Europe Market Share, By Country to 2025 to 2035
Fig 53: Europe Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 54: Europe Market Attractiveness Index, By Country to 2025 to 2035
Fig 55: East Asia Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Portability to 2025 to 2035
Fig 58: East Asia Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 59: East Asia Market Attractiveness Index, By Portability to 2025 to 2035
Fig 60: East Asia Market Share, By Product to 2025 to 2035
Fig 61: East Asia Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 62: East Asia Market Attractiveness Index, By Product to 2025 to 2035
Fig 63: East Asia Market Share, By Application to 2025 to 2035
Fig 64: East Asia Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 65: East Asia Market Attractiveness Index, By Application to 2025 to 2035
Fig 66: East Asia Market Share, By End User to 2025 to 2035
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 68: East Asia Market Attractiveness Index, By End User to 2025 to 2035
Fig 69: East Asia Market Share, By Country to 2025 to 2035
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 71: East Asia Market Attractiveness Index, By Country to 2025 to 2035
Fig 72: South Asia Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Portability to 2025 to 2035
Fig 75: South Asia Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 76: South Asia Market Attractiveness Index, By Portability to 2025 to 2035
Fig 77: South Asia Market Share, By Product to 2025 to 2035
Fig 78: South Asia Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 79: South Asia Market Attractiveness Index, By Product to 2025 to 2035
Fig 80: South Asia Market Share, By Application to 2025 to 2035
Fig 81: South Asia Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 82: South Asia Market Attractiveness Index, By Application to 2025 to 2035
Fig 83: South Asia Market Share, By End User to 2025 to 2035
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 85: South Asia Market Attractiveness Index, By End User to 2025 to 2035
Fig 86: South Asia Market Share, By Country to 2025 to 2035
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 88: South Asia Market Attractiveness Index, By Country to 2025 to 2035
Fig 89: Latin America Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Portability to 2025 to 2035
Fig 92: Latin America Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 93: Latin America Market Attractiveness Index, By Portability to 2025 to 2035
Fig 94: Latin America Market Share, By Product to 2025 to 2035
Fig 95: Latin America Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 96: Latin America Market Attractiveness Index, By Product to 2025 to 2035
Fig 97: Latin America Market Share, By Application to 2025 to 2035
Fig 98: Latin America Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 99: Latin America Market Attractiveness Index, By Application to 2025 to 2035
Fig 100: Latin America Market Share, By End User to 2025 to 2035
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 102: Latin America Market Attractiveness Index, By End User to 2025 to 2035
Fig 103: Latin America Market Share, By Country to 2025 to 2035
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 105: Latin America Market Attractiveness Index, By Country to 2025 to 2035
Fig 106: MEA Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Portability to 2025 to 2035
Fig 109: MEA Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 110: MEA Market Attractiveness Index, By Portability to 2025 to 2035
Fig 111: MEA Market Share, By Product to 2025 to 2035
Fig 112: MEA Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 113: MEA Market Attractiveness Index, By Product to 2025 to 2035
Fig 114: MEA Market Share, By Application to 2025 to 2035
Fig 115: MEA Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 116: MEA Market Attractiveness Index, By Application to 2025 to 2035
Fig 117: MEA Market Share, By End User to 2025 to 2035
Fig 118: MEA Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 119: MEA Market Attractiveness Index, By End User to 2025 to 2035
Fig 120: MEA Market Share, By Country to 2025 to 2035
Fig 121: MEA Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 122: MEA Market Attractiveness Index, By Country to 2025 to 2035
Fig 123: Oceania Market Value (USD Thousand), Volume (Units) Forecast and Analysis, 2020 to 2035
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Portability to 2025 to 2035
Fig 126: Oceania Market Y-o-Y Growth Projections, By Portability to 2025 to 2035
Fig 127: Oceania Market Attractiveness Index, By Portability to 2025 to 2035
Fig 128: Oceania Market Share, By Product to 2025 to 2035
Fig 129: Oceania Market Y-o-Y Growth Projections, By Product to 2025 to 2035
Fig 130: Oceania Market Attractiveness Index, By Product to 2025 to 2035
Fig 131: Oceania Market Share, By Application to 2025 to 2035
Fig 132: Oceania Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 133: Oceania Market Attractiveness Index, By Application to 2025 to 2035
Fig 134: Oceania Market Share, By End User to 2025 to 2035
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 136: Oceania Market Attractiveness Index, By End User to 2025 to 2035
Fig 137: Oceania Market Share, By Country to 2025 to 2035
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 139: Oceania Market Attractiveness Index, By Country to 2025 to 2035
Fig 140: United States Market share by Portability, 2025
Fig 141: United States Market share by Product, 2025
Fig 142: United States Market Value (USD Million) and Forecast 2025 to 2035
Fig 143: United States Market Share by End User, 2025
Fig 144: Canada Market share by Portability, 2025
Fig 145: Canada Market share by Product, 2025
Fig 146: Canada Market Value (USD Million) and Forecast 2025 to 2035
Fig 147: Canada Market Share by End User, 2025
Fig 148: Germany Market share by Portability, 2025
Fig 149: Germany Market share by Product, 2025
Fig 150: Germany Market Value (USD Million) and Forecast 2025 to 2035
Fig 151: Germany Market Share by End User, 2025
Fig 152: United Kingdom Market share by Portability, 2025
Fig 153: United Kingdom Market share by Product, 2025
Fig 154: United Kingdom Market Value (USD Million) and Forecast 2025 to 2035
Fig 155: United Kingdom Market Share by End User, 2025
Fig 156: France Market share by Portability, 2025
Fig 157: France Market share by Product, 2025
Fig 158: France Market Value (USD Million) and Forecast 2025 to 2035
Fig 159: France Market Share by End User, 2025
Fig 160: Russia Market share by Portability, 2025
Fig 161: Russia Market share by Product, 2025
Fig 162: Russia Market Value (USD Million) and Forecast 2025 to 2035
Fig 163: Russia Market Share by End User, 2025
Fig 164: Spain Market share by Portability, 2025
Fig 165: Spain Market share by Product, 2025
Fig 166: Spain Market Value (USD Million) and Forecast 2025 to 2035
Fig 167: Spain Market Share by End User, 2025
Fig 168: Italy Market share by Portability, 2025
Fig 169: Italy Market share by Product, 2025
Fig 170: Italy Market Value (USD Million) and Forecast 2025 to 2035
Fig 171: Italy Market Share by End User, 2025
Fig 172: China Market share by Portability, 2025
Fig 173: China Market share by Product, 2025
Fig 174: China Market Value (USD Million) and Forecast 2025 to 2035
Fig 175: China Market Share by End User, 2025
Fig 176: Japan Market share by Portability, 2025
Fig 177: Japan Market share by Product, 2025
Fig 178: Japan Market Value (USD Million) and Forecast 2025 to 2035
Fig 179: Japan Market Share by End User, 2025
Fig 180: South Korea Market share by Portability, 2025
Fig 181: South Korea Market share by Product, 2025
Fig 182: South Korea Market Value (USD Million) and Forecast 2025 to 2035
Fig 183: South Korea Market Share by End User, 2025
Fig 184: India Market share by Portability, 2025
Fig 185: India Market share by Product, 2025
Fig 186: India Market Value (USD Million) and Forecast 2025 to 2035
Fig 187: India Market Share by End User, 2025
Fig 188: Singapore Market share by Portability, 2025
Fig 189: Singapore Market share by Product, 2025
Fig 190: Singapore Market Value (USD Million) and Forecast 2025 to 2035
Fig 191: Singapore Market Share by End User, 2025
Fig 192: Indonesia Market share by Portability, 2025
Fig 193: Indonesia Market share by Product, 2025
Fig 194: Indonesia Market Value (USD Million) and Forecast 2025 to 2035
Fig 195: Indonesia Market Share by End User, 2025
Fig 196: Thailand Market share by Portability, 2025
Fig 197: Thailand Market share by Product, 2025
Fig 198: Thailand Market Value (USD Million) and Forecast 2025 to 2035
Fig 199: Thailand Market Share by End User, 2025
Fig 200: Brazil Market share by Portability, 2025
Fig 201: Brazil Market share by Product, 2025
Fig 202: Brazil Market Value (USD Million) and Forecast 2025 to 2035
Fig 203: Brazil Market Share by End User, 2025
Fig 204: Mexico Market share by Portability, 2025
Fig 205: Mexico Market share by Product, 2025
Fig 206: Mexico Market Value (USD Million) and Forecast 2025 to 2035
Fig 207: Mexico Market Share by End User, 2025
Fig 208: Turkey Market share by Portability, 2025
Fig 209: Turkey Market share by Product, 2025
Fig 210: Turkey Market Value (USD Million) and Forecast 2025 to 2035
Fig 211: Turkey Market Share by End User, 2025
Fig 212: GCC Countries Market share by Portability, 2025
Fig 213: GCC Countries Market share by Product, 2025
Fig 214: GCC Countries Market Value (USD Million) and Forecast 2025 to 2035
Fig 215: GCC Countries Market Share by End User, 2025
Fig 216: South Africa Market share by Portability, 2025
Fig 217: South Africa Market share by Product, 2025
Fig 218: South Africa Market Value (USD Million) and Forecast 2025 to 2035
Fig 219: South Africa Market Share by End User, 2025
Fig 220: Australia Market share by Portability, 2025
Fig 221: Australia Market share by Product, 2025
Fig 222: Australia Market Value (USD Million) and Forecast 2025 to 2035
Fig 223: Australia Market Share by End User, 2025
Fig 224: New Zealand Market share by Portability, 2025
Fig 225: New Zealand Market share by Product, 2025
Fig 226: New Zealand Market Value (USD Million) and Forecast 2025 to 2035
Fig 227: New Zealand Market Share by End User, 2025
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the oxygen therapy equipment market?
The industry is slated to reach USD 4.2 billion in 2025.
What is the outlook on oxygen therapy equipment sales?
The oxygen therapy equipment is projected to reach a size of USD 10.2 billion by 2035.
Who are the major oxygen therapy equipment companies?
Key companies include Philips Healthcare, Inogen, Inc., Teleflex Inc., Drägerwerk AG & Co. KGaA, Chart Industries, Inc., Smiths Medical, GE Healthcare, Invacare Corporation, Linde Healthcare, Fisher & Paykel Healthcare Ltd., and Taiyo Nippon Sanso Corporation.
Which country is slated to observe the fastest growth in the oxygen therapy equipment industry?
China, slated to grow at 8.1% CAGR during the forecast period, is poised for the fastest growth.
Which oxygen therapy equipment products are being widely used?
Stationary oxygen devices are being widely used.